| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.3 |
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | 0.17 | 0.3 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.3 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |